-
Acute Bacterial Skin and Skin Structure Infections Market to Grow Substantially by 2032, Assesses DelveInsight | Key Companies - Melinta, AbbVie, Basilea, Motif Bio, Cubist, Paratek, Durata, The Medicine Company
23 Aug 2023 17:00 GMT
… about ABSSSI treatment, visit @ ABSSSI Treatment Drugs Key … Medicine Company
Tygacil (Tigecycline): Weyth Pharmaceutical
Cubicin (Daptomycin): Cubist Pharmaceutical
… the FDA-approved drugs for ABSSSI @ Drugs for … drugs in development @ ABSSSI Clinical Trials …
-
Tigecycline Drug Market Positive Outlook, Opportunities And Industry Expansion By 2028
13 Jul 2022 07:39 GMT
…
Pfizer
ACTIZA Pharmaceutical
Salvavidas Pharmaceutical Pvt
Biocon
The Tigecycline Drugmarket can be … the global Tigecycline DrugMarket based on Types are:
Tygacil
Generic
Based … on Application, the Global Tigecycline DrugMarket is …
-
Global Geriatric Medicines Market to Witness Positive Growth of 6% Through 2026
11 Jun 2021 00:46 GMT
… of hospital visits for treatment of various chronic … in clinical trials to develop critical drug formulations which … Pharmaceutica Ltd. for marketing CRESEMBA, an anti-fungal medicine … medications are Zithromax, Zyvox, Zavicefta, Cresemba, Vfend and Tygacil. …
-
Paratek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting Chance
18 Sep 2020 03:48 GMT
… FDA’s scientists and doctors thought highly of the drug … , developing Tygacil, a successful antibiotic treatment that made … NASDAQ:MLNT) and Tetraphase Pharmaceuticals (NASDAQ:TTPH). Funding … pharma, healthcare and biotech investment recommendations and research …
-
Paratek Pharmaceuticals: The Best Bet In A Bad Space
01 Feb 2020 00:07 GMT
… provided below. Company Overview Paratek Pharmaceuticals, Inc. (PRTK) is a … approved as an oral-only remedy for CAPB, for which … Synercid; as well as CABP treatments Zyvox, Tygacil, and Teflaro. The point … , The Biotech Forum. Try a free 2-week trial today by …
-
Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman
25 Jun 2019 20:01 GMT
… with Transcept Pharmaceuticals, Dr. Loh was Chief Medical Officer … a variety of products including Tygacil, ciprofloxacin, Zosyn®, Xeljanz®, … oral formulations for the treatment of community-acquired … , atypicals, and other drug-resistant strains. Please see …
-
2019 Drug Insight: Tygacil - Product Details, Sales Assessment, Patent Details, Market Competition, Emerging Therapies - ResearchAndMarkets.com
18 Feb 2019 20:26 GMT
… ;s offering.
Tygacil Drug Insight, 2019 highlights the drug marketed details and … for target finding, drug repurposing, and precision medicineIdentify and plan ahead … Global API Manufacturers Assessment
Active Pharmaceutical Ingredient (API) Manufacturers by …
-
The Outlook For Pfizer’s Anti-Infective Drugs Business
29 Nov 2017 14:28 GMT
… (NYSE:PFE) anti-infective drugs account for close to 12% … be attributed to a single drug family – Prevnar. The company … drugs in its anti-infective portfolio, including Zyvox, Vfend, Zmax and Tygacil … compounds in its phase 3 trials. This suggests that we are …
-
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market to See Incredible Growth by 2018 End
29 Nov 2017 06:26 GMT
… Staphylococcus Aureus (MRSA) Drugs Market: Global Industry Analysis … Other options for the treatment of MRSA infection are … prime brand-names such as Tygacil, Cubicin, Zyvox, and … PLC, Pfizer, Inc., Cubist Pharmaceuticals, Inc., ViroPharma, Inc., Forest …